1. Home
  2. SACH vs BHST Comparison

SACH vs BHST Comparison

Compare SACH & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

N/A

Current Price

$0.91

Market Cap

38.4M

Sector

Real Estate

ML Signal

N/A

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$1.49

Market Cap

41.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SACH
BHST
Founded
2010
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
38.4M
41.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
SACH
BHST
Price
$0.91
$1.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
★ 165.1K
31.0K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 21.74%
N/A
EPS Growth
★ 104.30
N/A
EPS
N/A
★ N/A
Revenue
★ $57,500,000.00
N/A
Revenue This Year
$94.91
$8.59
Revenue Next Year
N/A
$29.48
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.76
$1.42
52 Week High
$1.45
$12.80

Technical Indicators

Market Signals
Indicator
SACH
BHST
Relative Strength Index (RSI) 52.63 28.91
Support Level $0.91 N/A
Resistance Level $0.99 $1.77
Average True Range (ATR) 0.03 0.10
MACD -0.01 0.00
Stochastic Oscillator 19.82 15.73

Price Performance

Historical Comparison
SACH
BHST

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

Share on Social Networks: